https://scholars.lib.ntu.edu.tw/handle/123456789/624299
標題: | A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study | 作者: | Su, Yung-Yeh Chiu, Yen-Feng Li, Chung-Pin SHIH-HUNG YANG Lin, Johnson Lin, Shyh-Jer Chang, Ping-Ying Chiang, Nai-Jung Shan, Yan-Shen Ch'ang, Hui-Ju Chen, Li-Tzong |
關鍵字: | PACLITAXEL PLUS GEMCITABINE; MULTICENTER; OXALIPLATIN; FOLFIRINOX; JAPAN; FLUOROURACIL; SURVIVAL; THERAPY; SOCIETY; S-1 | 公開日期: | 2022 | 出版社: | SPRINGERNATURE | 卷: | 126 | 期: | 7 | 起(迄)頁: | 1018 | 來源出版物: | British journal of cancer | 摘要: | The objective of this study was to evaluate the efficacy and safety of induction chemotherapy (ICT), GOFL (gemcitabine, oxaliplatin plus fluorouracil (5-FU)/leucovorin) versus modified FOLFIRINOX (irinotecan, oxaliplatin plus 5-FU/leucovorin), followed by concurrent chemoradiotherapy (CCRT) in locally advanced pancreatic adenocarcinoma (LAPC). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/624299 | ISSN: | 0007-0920 | DOI: | 10.1038/s41416-021-01649-7 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。